» Authors » Gretchen L Gierach

Gretchen L Gierach

Explore the profile of Gretchen L Gierach including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 166
Citations 2702
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Harris A, Hughes J, Lawrence W, Lenz P, Franklin J, Bhawsar P, et al.
JAMA Netw Open . 2025 Feb; 8(2):e2461334. PMID: 39992653
Importance: Inflammation impacts cancer risk and tumor biological processes, yet studies linking it to social and environmental risk factors are lacking. Objective: To investigate the association of neighborhood deprivation and...
2.
Burke A, ODriscoll J, Abubakar M, Bennett K, Carmody E, Flanagan F, et al.
NPJ Breast Cancer . 2025 Feb; 11(1):16. PMID: 39955290
Benign breast disease (BBD) is associated with heterogeneous breast cancer risk. Identifying key breast cancer risk factors for this population may inform breast cancer prevention or early detection strategies. We...
3.
Mulder C, Yang X, Jee Y, Scott C, Gao C, Cao Y, et al.
Res Sq . 2025 Jan; PMID: 39764121
Introduction: Incorporation of mammographic density to breast cancer risk models could improve risk stratification to tailor screening and prevention strategies according to risk. Robust evaluation of the value of adding...
4.
Koka H, Tian Y, Deng L, Yu K, Li E, Guo C, et al.
Cancer Epidemiol Biomarkers Prev . 2024 Nov; 34(2):260-269. PMID: 39535536
Background: Increased mammographic density (MD) is a known breast cancer risk factor, but its influencing factors are unclear in Asian populations. This study examined the links between known breast cancer...
5.
Ghosh R, Pfeiffer R, Roberts S, Gierach G, Dallal C
Cancer Causes Control . 2024 Oct; 36(2):107-126. PMID: 39382775
Purpose: Randomized clinical trials support reductions in contralateral breast cancer (CBC) risk with use of adjuvant endocrine therapy, however, real-world treatment effects, particularly for subgroups of breast cancer survivors, remain...
6.
Peeri N, Bertrand K, Na R, De Vivo I, Setiawan V, Seshan V, et al.
J Natl Cancer Inst . 2024 Sep; 117(1):76-88. PMID: 39235934
Background: The American Cancer Society recommends physicians inform average-risk women about endometrial cancer risk on reaching menopause, but new diagnoses are rising fastest in women aged younger than 50 years....
7.
Madrigal J, Pruitt C, Fisher J, Liao L, Graubard B, Gierach G, et al.
Environ Int . 2024 Sep; 191:108985. PMID: 39226766
Background: Chemicals emitted from industrial facilities include known or suspected mammary carcinogens and endocrine disruptors, but epidemiologic studies are limited. We evaluated associations between air emissions of multiple carcinogenic chemicals...
8.
Aiello Bowles E, Ramin C, Vo J, Feigelson H, Gander J, Veiga L, et al.
Breast Cancer Res Treat . 2024 Aug; 208(3):577-587. PMID: 39148003
Purpose: Trials demonstrating benefits of tamoxifen for women with ductal carcinoma in situ (DCIS) were published > 20 years ago; yet subsequent uptake of endocrine therapy was low. We estimated...
9.
Hurson A, Ahearn T, Koka H, Jenkins B, Harris A, Roberts S, et al.
medRxiv . 2024 Aug; PMID: 39108508
Background: Breast cancer is comprised of distinct molecular subtypes. Studies have reported differences in risk factor associations with breast cancer subtypes, especially by tumor estrogen receptor (ER) status, but their...
10.
Titus L, Hatch E, Bertrand K, Palmer J, Strohsnitter W, Huo D, et al.
Cancers (Basel) . 2024 Jul; 16(14). PMID: 39061214
Background: Females exposed prenatally to diethylstilbestrol (DES) have an elevated risk of cervical dysplasia, breast cancer, and clear cell adenocarcinoma (CCA) of the cervix/vagina. Testicular cancer risk is increased in...